SCARLETRED is a leading health AI company providing objective skin imaging and analysis SaaS for biopharma, dermatologists and patients
SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connects to our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 1, 2017 | Non-Equity Assistant | €100K | 1 | Die Wirtschaftskammer | — | Detail |
Oct 1, 2015 | Non-Equity Assistant | €300K | 1 | Die Wirtschaftskammer | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Die Wirtschaftskammer | Yes | Non-Equity Assistant |